Though there is no direct evidence to elucidate the mechanism for m6A-regulated amino acid metabolism, a series of vital signature pathways such as mTOR have been reported to be tightly controlled by m6A, thus providing a novel avenue for cancer therapy by targeting a m6A-amino acid axis [130]. This evidence concerns the gene MTOR and cancer.